In a pre-clinical study using a TC1 tumor in C57BL/6 mice, a pan-inhibitor of all three TGF-β isoforms had no impact as a single agent, suggesting that the mechanism of immunosuppression was different from that in 15-12RM. The gene discussed is TGFB1; the disease is neoplasm.